Recent updates - Health U Fit

BioArctic AB's (publ) (Nasdaq: BIOA B) (Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for Leqembi,

07 Mar2024

BioArctic’s Partner Eisai Presents Updated Sales Simulation For Leqembi® At Its Annual Press Conference

By Healthufit March 7, 2024March 7, 2024

BioArctic's Partner Eisai Presents Updated Sales Simulation For Leqembi® A...

Asceneuron SA, a clinical stage biotech company dedicated to targeting the root causes of neurodegenerative diseases, today announces the appointments of neurodegenerative disease

06 Mar2024

Asceneuron Expands Scientific Advisory Board With World Leading Experts In Neurodegenerative Diseases

By Healthufit March 6, 2024March 6, 2024

Asceneuron Expands Scientific Advisory Board With World Leading Experts In...

Seattle Children's Research Institute, the research division of Seattle Children's Hospital and renowned global leader in pediatric research, and Genezen, a leading gene and cell therapy contract development and manufacturing organization,

06 Mar2024

Genezen Announces Strategic Process Development and Manufacturing Partnership Agreement with Seattle Children’s Research Institute for X-linked Agammaglobulinemia (XLA) Cell Therapy Program

By Healthufit March 6, 2024March 6, 2024

Genezen Announces Strategic Process Development and Manufacturing Partnersh...

Baraya Extended Care KSA has launched its first rehabilitation outpatient clinic in Riyadh, Saudi Arabia, offering physical, occupational, speech and language therapy,

06 Mar2024

TVM Capital Healthcare Announces the Opening of Baraya Extended Care’s First Outpatient Rehabilitation Clinic in Riyadh

By Healthufit March 6, 2024March 6, 2024

TVM Capital Healthcare Announces the Opening of Baraya Extended Care's Firs...

Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need,

22 Feb2024

Medivir Presents Data That Strengthens The Fostrox/Lenvima Combination In Primary Liver Cancer At EASL Liver Cancer Summit

By Healthufit February 22, 2024February 22, 2024

Medivir Presents Data That Strengthens The Fostrox/Lenvima Combination In P...

Previous page 1 … 25 26 27 28 29 30 Next page

Healthufit is a catalyst for positive transformation, which has been inspiring millions of individuals each month to embrace proactive steps toward a healthier and more fulfilling life. Our profound understanding enables us to engage with people at every stage of their well-being expedition, providing access to scientifically-backed content, supportive communities, and effective solutions precisely when they’re needed.

Information

Get the Health U Fit Updates Delivered to your Inbox!

Subscibe for FREE! Get the Health and Wellness info to your inbox before everyone else.

Email Address

FOLLOW US